As the world ponders the possibility of GFC2 its population just keeps on growing at a rate of about 2.5million people per week.
In a nutshell the world of diagnostics just keeps on growing its customer base.
All holds up well if your a Company with the ability to seize a large exposure in this market.
At a 20% discount to where it was only two weeks ago, I suspect the risk reward ratio has improved significantly for this stock based upon the same fundamentals it had two weeks ago.
Other than that - nothing has changed - still awaiting for a sign of ink on paper.
IMO DYOR
ADO Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
